Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.Lehmann, F., Haile, S., Axen, E., Medina, C., Uppenberg, J., Svensson, S., Lundback, T., Rondahl, L., Barf, T.
(2004) Bioorg Med Chem Lett 14: 4445-4448
- PubMed: 15357969
- DOI: https://doi.org/10.1016/j.bmcl.2004.06.057
- Primary Citation of Related Structures:
- PubMed Abstract:
Low micromolar human A-FABP inhibitors were found by utilizing a fluorescence polarization assay, X-ray crystallography and modeling. The carbazole- and indole-based inhibitors displayed approximately 10-fold preferences over human H-FABP and E-FABP, and are highly selective against I-FABP. This communication describes the SAR for drug-like synthetic inhibitors of human A-FABP.
Department of Medicinal Chemistry, Biovitrum AB, SE-751 37 Uppsala, Sweden.